Back to announcement
20231031_PRDA_Laporan Informasi dan Fakta Material_31483815_lamp1.pdf
Other Text extracted PRDASource file signed link, expires in 15 minutes
Extracted text 4
Page 1
BERITA PERS
Untuk diterbitkan segera
TETAP OPTIMIS CAPAI TARGET AKHIR TAHUN, PRODIA FOKUS GENJOT PERFORMA
JAKARTA, 30 Oktober 2023 – Memasuki kuartal JAKARTA, October 30, 2023 - Entering the third
ketiga di tahun ini, PT Prodia Widyahusada Tbk. quarter of this year, PT Prodia Widyahusada Tbk
(PRDA) kembali mencatat kinerja yang baik meski (PRDA) recorded another good performance despite
terdapat resistensi pertumbuhan. tercatat sebesar growth resistance. Revenue from contracts with
Rp 1.612,4 miliar atau 1,6 triliun dengan customers was recorded at Rp 1,612.4 billion or 1.6
pertumbuhan 2% year on year (YoY). Perseroan trillion with a growth of 2% year on year (YoY). The
masih mampu mempertahankan pertumbuhan Company is able to maintain positive growth in a
positif dalam lingkungan ekonomi yang sulit, hal ini challenging economic environment, which proves the
membuktikan ketahanan dan konsistensi bisnis resilience and consistency of the Company's business.
Perseroan. Liana Kuswandi, Direktur Keuangan Optimistic that it can still achieve its year-end target,
Prodia, menambahkan bahwa Perseroan masih the Company continues to boost performance with a
optimis masih dapat mencapai target akhir tahun, focus on digital development, said Prodia’s Finance
Perseroan terus menggenjot performa dengan fokus Director, Liana Kuswandi.
pada pengembangan digital.
Melihat dari laporan posisi keuangan konsolidasian Looking at the Company's consolidated financial
Perseroan, total aset tercatat sebesar Rp 2.691,5 position report, total assets were recorded at Rp
miliar atau 2,7 triliun, dan total ekuitas tercatat 2,691.5 billion or 2.7 trillion, and total equity was
sebesar Rp 2.344,8 miliar atau 2,3 triliun. Total recorded at Rp 2,344.8 billion or 2.3 trillion. Total
liabilitas turun 3,3% dari Rp 358,4 miliar menjadi Rp liabilities decreased by 3.3% from Rp 358.4 billion to
346,7 miliar. Sehingga, total liabilitas dan ekuitas Rp 346.7 billion. Thus, total liabilities and equity
tercatat menjadi Rp 2.691,5 miliar di posisi 30 recorded to Rp 2,691.5 billion as of September 30,
September 2023. Posisi keuangan tersebut didorong 2023. The financial position was driven by the
dengan adanya ekspansi dalam kegiatan usaha expansion of the Company's business activities.
Perseroan. Selain itu, adanya penurunan liabilitas Furthermore, the decrease in the Company's liabilities
Perseroan membuktikan bahwa Perseroan mampu proves that the Company is capable of managing
mengelola kewajiban keuangan secara efisien. financial obligations efficiently. The Company
Perseroan senantiasa mengelola sumber daya consistently manages resources better to create the
dengan lebih baik guna menciptakan kestabilan yang stability needed for long-term growth.
diperlukan untuk pertumbuhan jangka panjang.
Adapun, laporan laba rugi Perseroan tetap Meanwhile, the Company's income statement
memperoleh performa kinerja yang positif, kendati continued to have a positive performance, despite
terdapat resistensi pertumbuhan yang disebabkan the growth resistance caused by the high base in the
oleh base yang cukup tinggi di tahun sebelumnya. previous year. Revenue from routine tests still
Tercatat pendapatan dari pemeriksaan tes rutin dominated the revenue contribution to the
masih mendominasi kontribusi pendapatan terhadap Company's total revenue of 69% or Rp 1.1 trillion with
total pendapatan Perseroan sebesar 69% atau Rp 1,1 esoteric and non-lab tests contributing 23% and 8%
triliun dengan tes esoterik dan non-lab masing- respectively. Meanwhile, the Company's net profit
masing berkontribusi sebesar 23% dan 8%. Adapun, was recorded at Rp 235.5 billion until September
laba bersih Perseroan tercatat sebesar Rp 235,5 2023, slightly normalized due to the increase in
miliar sampai dengan September 2023, sedikit several costs due to inflation this year.
Page 2
mengalami normalisasi karena adanya kenaikan beberapa biaya akibat kenaikan inflasi tahun ini. Arus kas dari aktivitas operasi Perseroan naik 35,1% The Company's cash flow from operating activities yoy dari Rp 255,9 miliar menjadi Rp 345,8 miliar. Hal increased 35.1% yoy from Rp 255.9 billion to Rp 345.8 ini menunjukkan optimalisasi dalam pengelolaan billion. This shows optimization in the management piutang dan hutang Perseroan yang pada akhirnya of the Company’s receivables and payables which in dapat menghasilkan peningkatan arus kas operasi. turn can result in an increase in operating cash flow. Arus kas dari aktivitas investasi Perseroan turun Cash flows from investing activities decreased to menjadi negatif Rp 298,8 miliar, dikarenakan adanya negative Rp 298.8 billion, due to an increase in kenaikan investasi digitalisasi dan penambahan uang investment to digitalization and additional advances muka untuk pembelian aset tetap. Hal ini menjadi for the purchase of fixed assets. This is part of the bagian dari strategi jangka panjang Perseroan dalam Company's long-term strategy in investment to investasi digitalisasi dan pembelian aset tetap untuk digitalization and acquiring fixed assets to support mendukung pertumbuhan bisnis Perseroan. Adapun the Company's business growth. Cash flows from Arus kas dari aktivitas pendanaan tercatat negatif Rp financing activities were negative Rp 195.9 billion. 195,9 miliar. Meskipun terjadi penurunan 3% dalam Although there was a 3% decrease in cash and cash kas dan setara kas pada akhir tahun menjadi Rp 549,5 equivalents at the end of the year to Rp 549.5 billion miliar dibandingkan kuartal tahun sebelumnya, compared to the previous quarter, the presence of an keberadaan jumlah kas yang cukup masih adequate cash amount still provides confidence that memberikan keyakinan bahwa Perseroan memiliki the Company has a strong financial capability to kemampuan finansial yang kuat untuk mendukung support its operational business. Effective cash flow bisnis operasional Perseroan. Pengelolaan arus kas management and a strong financial foundation to yang efektif dan fondasi keuangan yang kokoh untuk support long-term business growth serve as the mendukung pertumbuhan bisnis jangka panjang Company's preparation to confidently achieve its menjadi bekal Perseroan untuk optimis mencapai targets by the end of the year. target di akhir tahun. Perseroan juga terus memperhatikan faktor-faktor The Company always continue to pay attention to seasonality cost untuk menjaga stabilitas keuangan seasonality cost factors to maintain the company's perusahaan sepanjang tahun, dan tetap memberikan financial stability throughout the year, and also layanan yang berkualitas kepada pelanggan. continue to provide quality services to customers. The Perseroan juga akan terus mengoptimalkan dan Company will also continue to optimize and diversify diversifikasi portofolio produk dan layanan mereka their product and service portfolio to increase off- untuk meningkatkan pendapatan di luar musim season revenue and achieve long-term stable growth. tertentu dan mencapai pertumbuhan yang stabil The Company continues to survive and innovate in the pada jangka panjang. Perseroan tetap bertahan dan face of various challenges and dynamics. The berinovasi dalam menghadapi berbagai tantangan Company also remains focused on developing dan dinamika. Perusahaan juga tetap fokus pada superior services, innovating and adopting new pengembangan layanan unggulan, inovasi dan technologies, improving operational efficiency, and mengadopsi teknologi baru, peningkatan efisiensi commitment to service quality and patient safety operasional, dan komitmen terhadap kualitas which are expected to continue bringing positive layanan dan keamanan pasien yang diharapkan akan performance until the end of this year. tetap membawa kinerja yang positif hingga akhir tahun ini. Tentang PT Prodia Widyahusada Tbk. About PT Prodia Widyahusada Tbk. Laboratorium klinik Prodia didirikan pertama kali di Solo pada 7 Prodia Clinical Laboratory was first established in Solo on May 7, Mei 1973 oleh beberapa orang idealis berlatar belakang 1973, by several idealists with pharmaceutical education
Page 3
pendidikan farmasi. Sejak awal, Dr. Andi Widjaja, MBA beserta background. Since the beginning, Dr. Andi Widjaja, MBA and the
seluruh pendiri lainnya tetap menjaga komitmen untuk other founders have maintained the commitment to provide the
mempersembahkan hasil pemeriksaan terbaik dengan layanan best examination results with wholehearted service.
sepenuh hati.
Seluruh cabang Prodia telah mendapatkan akreditasi, baik di All Prodia branches have been accredited, both nationally and
tingkat nasional maupun internasional. Salah satunya dari College internationally. One of them is from the College of American
of American Pathologist (CAP), sebuah Lembaga profesi bidang Pathologist (CAP), a professional organization in the field of health
laboratorium kesehatan di Amerika Serikat yang mendapatkan laboratory in the United States that has received international
pengakuan internasional – selama 10 tahun berturut-turut. recognition - for 10 consecutive years. With this CAP Accreditation,
Dengan Akreditasi CAP ini, kualitas standar suatu Laboratorium the standard quality of a clinical laboratory is assessed based on
klinik dinilai berdasarkan acuan Internasional, karenanya hasil international reference, therefore Prodia's results can be used not
Prodia dapat dipergunakan tidak hanya di dalam negeri tetapi juga only domestically but also internationally. Thus, the quality of test
di mancanegara. Sehingga kualitas hasil tes dari laboratorium results from Prodia laboratory is in line with international
Prodia sejajar dengan laboratorium internasional. laboratories.
Pada 7 Desember 2016, Bursa Efek Indonesia (BEI) meresmikan On December 7, 2016, Indonesia Stock Exchange (IDX) inaugurated
pencatatan saham perdana Prodia sebagai emiten ke-15 di tahun the listing of Prodia's first share as the 15th issuer in 2016, with the
2016, dengan kode saham “PRDA”. Dalam aksi korporasi itu, Prodia stock code "PRDA". In the corporate action, Prodia offered 187.5
telah menawarkan saham perdana sebanyak 187,5 juta lembar million shares of its initial public offering. Thus, the funds raised
saham. Dengan demikian, dana yang diraih dari penawaran umum from the company's initial public offering (IPO) amounted to
perdana saham (IPO) perseroan mencapai sebesar Rp1,22 triliun. Rp1.22 trillion.
Hingga 30 September 2023, Prodia telah mengoperasikan jejaring As of September 30, 2023, Prodia has operated a service network
layanan sebanyak 290 outlet, di 78 Kota, 86 Kabupaten, dan 34 of 290 outlets in 78 cities, 86 regencies, and 34 provinces
Propinsi dan di seluruh Indonesia, beberapa diantaranya throughout Indonesia, some of which are Prodia Health Care (PHC),
merupakan Prodia Health Care (PHC) yakni layanan wellness clinic a wellness clinic service based on personalized medicine and
yang berbasis personalized medicine serta specialty clinics yang specialty clinics consisting of Prodia Children's Health Centre
terdiri dari Prodia Children’s Health Centre (PCHC), Prodia (PCHC), Prodia Women's Health Centre (PWHC) and Prodia Senior
Women’s Health Centre (PWHC) dan Prodia Senior Health Centre Health Centre (PSHC).
(PSHC).
Prodia has launched Contact Prodia including call center 1500-830
Prodia telah meluncurkan Kontak Prodia diantaranya call centre and online-based virtual personal assistant Tanya Prodia (TANIA)
1500-830 dan personal assistant virtual berbasis online Tanya which can be accessed through Whatsapp 08551500830,
Prodia (TANIA) yang dapat diakses melalui Whatsapp Telegram: @prodia.id, Facebook Messenger: @prodia.id and
08551500830, Telegram: @prodia.id, Facebook Messenger: Prodia Web Widget: www.prodia.co.id. Prodia's services can also
@prodia.id dan Web Widget Prodia: www.prodia.co.id. Layanan be accessed through U by Prodia App which can be downloaded
Prodia juga dapat dijangkau melalui Aplikasi U by Prodia yang through App Store & PlayStore.
dapat diunduh melalui App Store & PlayStore.
Untuk informasi lebih lanjut, dapat mengunjungi For more information, please visit www.prodia.co.id or
www.prodia.co.id atau menghubungi: contact:
Marina Eka Amalia Stephanie Setiawan
Corporate Secretary Head of Investor Relation
PT Prodia Widyahusada Tbk. PT Prodia Widyahusada Tbk.
Ph. +62-21-3144182 Ph. +62-21 3144182
Email corporate.secretary@prodia.co.id E-mail investor.relation@prodia.co.id
******
Page 4
Names mentioned 0 people and organisations named in the text · linked when the evidence is strong
The name pass has not read this document yet.
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.